Frequenly Asked Questions about Right to Choose and the Neurodevelopment Assessment Pathway
Neurodevelopment Assessment Pathway Right to Choose FAQs
In recent months the Beyond CYP Transformation Programme team have been developing a comprehensive set of FAQs for families to provide clear, accurate information on Right to Choose neurodevelopmental assessments.
It is really important to check out all of the information available about the Right to Choose option before progressing down this route as a any diagnosis / medication suggestion would still need to be accepted locally by NHS services.
These FAQs are now live and can be viewed on the ICB website: Families - NHS Cheshire and Merseyside
Re-sharing the general FAQs regarding accessing ND assessments:
Neurodevelopment Assessment Pathway FAQs
Do you find it confusing finding out how to access ND assessments?
WarrPAC have been working with partners to develop a set of Frequently Asked Questions which aims to answer questions regarding the neurodevelopmental pathway (NDP) for the assessment of Attention Deficit Hyperactivity Disorder (ADHD) and Autism.
We have done this by collecting your views - we thank you for your contributions which we have passed on to professionals for ongoing development of FAQs.
